Literature DB >> 9289

Experimental infusion thrombophlebitis. Importance of the infusion rate.

I Hessov, M Bojsen-Møller.   

Abstract

The importance of the method of administration of acid glucose infusions for the venous inflammatory response has been investigated in two series of experimental trials. 60 ml of 5% glucose solution was administered into rabbit-ear veins in three ways: 1) continuously over 5 hours (slow infusion), 2) continuously over 1 hour (rapid infusion), 3) discontinuously during 2 X 30 minutes with an interval of 4 hours (discontinuous infusion). Microscopical examination of the veins revealed that the inflammatory changes were less pronounced after rapid and discontinuous infusions than after slow infusions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9289     DOI: 10.1007/BF01886124

Source DB:  PubMed          Journal:  Eur J Intensive Care Med        ISSN: 0340-0964


  9 in total

1.  Experimental infusion thrombophlebitis. Importance of the pH of glucose solutions.

Authors:  I Hessov; M Bojsen-Møller
Journal:  Eur J Intensive Care Med       Date:  1976-09

2.  [Frequency of superficial thrombophlebitis after intravenous infusion].

Authors:  T SKAJAA; J DAHL; J K JENSEN; N KVISSELGAARD
Journal:  Nord Med       Date:  1961-10-19

3.  THROMBOPHLEBITIS following intravenous infusions: trial of plastic and red rubber giving-sets; report to the Medical Research Council by a subcommittee of the Council's Blood Transfusion Research Committee.

Authors: 
Journal:  Lancet       Date:  1957-03-23       Impact factor: 79.321

4.  Venous catheterization for continuous parenteral fluid therapy; use of heparin in delaying thrombophlebitis.

Authors:  L H ANDERSON; S L ALDRICH; B HALPERN; R E DOLKART
Journal:  J Lab Clin Med       Date:  1951-10

5.  Heparin in the prevention of infusion phlebitis. A double-blind controlled study.

Authors:  H W Daniell
Journal:  JAMA       Date:  1973-12-10       Impact factor: 56.272

6.  Use of percutaneously inserted venous catheters in coronary care units.

Authors:  M H Sketch; M Cale; S M Mohiuddin; R W Booth
Journal:  Chest       Date:  1972-12       Impact factor: 9.410

7.  Thrombophlebitis following intravenous lignocaine infusion.

Authors:  K Nordell; L Mogensen; O Nyquist; E Orinius
Journal:  Acta Med Scand       Date:  1972-10

8.  Infusion thrombophlebitis.

Authors:  F Andreasen
Journal:  Dan Med Bull       Date:  1969-05

9.  Utilization of intravenous glucose and fructose in the postoperative period.

Authors:  I Hessov
Journal:  Acta Chir Scand       Date:  1975
  9 in total
  5 in total

1.  Experimental infusion thrombophlebitis. Importance of the pH of glucose solutions.

Authors:  I Hessov; M Bojsen-Møller
Journal:  Eur J Intensive Care Med       Date:  1976-09

2.  Development of thrombophlebitis in peripheral veins with Vialon and PTFE-Teflon cannulas: a double-blind, randomised, controlled trial.

Authors:  J J Payne-James; J Rogers; M J Bray; S K Rana; D McSwiggan; D B Silk
Journal:  Ann R Coll Surg Engl       Date:  1991-09       Impact factor: 1.891

3.  Do fat emulsions protect against infusion thrombophlebitis? An experimental study.

Authors:  I Hessov; M Bojsen-Møller; F Melsen
Journal:  Intensive Care Med       Date:  1978-07       Impact factor: 17.440

4.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas.

Authors:  C Jorup-Rönström; S Britton; A Gavlevik; K Gunnarsson; A C Redman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

Review 5.  Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care.

Authors:  Timothy Valk; Carol McMorrow
Journal:  SAGE Open Med       Date:  2020-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.